Latest News

NeoVolta has been making headlines with its recently reported jump in sales, the release of new commercial and industrial energy storage solutions, and an announcement of plans to acquire key assets from Neubau Energy. These moves came after news of the company’s addition to the S&P Global BMI Index, catching the attention of investors looking for growth stories in energy storage. See our latest analysis for NeoVolta. On the heels of its index addition and those recent new product launches,...

BlackRock’s iShares Bitcoin Trust ETF has recently overtaken Deribit as the world’s largest venue for Bitcoin options trading, marking a major shift toward regulated, U.S.-based digital asset markets. This transition reflects a meaningful increase in institutional demand and signals Wall Street’s expanding influence over both spot and derivatives crypto markets. We’ll explore how IBIT’s rapid leadership in the Bitcoin options market cements its evolving role in institutional digital asset...

VisionSys AI (VSA) continues to operate at a loss, but over the past five years, the company has managed to cut its losses by an average of 30.3% per year. While its Price-to-Sales Ratio stands at 1.6x, matching the US Consumer Services industry average and notably lower than the peer group’s 5.8x, there is still no clear sign of profit growth momentum or improvement in net profit margins. Investors are left weighing a steadily improving loss profile and apparently attractive valuation...

Waga Energy (ENXTPA:WAGA) is expected to deliver rapid revenue growth of 59.3% per year, far ahead of the French market's forecasted 5.4% per year. Still, the company remains unprofitable, with losses having increased at a rate of 33% annually over the past five years and profit margins showing no sign of recovery. This combination of high growth, ongoing lack of profitability, and a premium Price-To-Sales ratio of 9.7x positions Waga Energy as a high-risk, high-reward play for investors...

As U.S. markets continue to rise, with major indices setting fresh records despite concerns over a government shutdown, investors are exploring opportunities beyond the traditional blue-chip stocks. Penny stocks, often seen as relics of past speculative trading days, still hold potential when backed by strong financials and solid business models. These smaller or newer companies can offer unique growth prospects and hidden value for those willing to explore beyond the well-trodden paths of...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Just because a business does not make any money, does not mean that the stock will go down. By way of example, Kodiak...

It is doubtless a positive to see that the Cresco Labs Inc. ( CSE:CL ) share price has gained some 200% in the last...

Despite an already strong run, Harrow, Inc. ( NASDAQ:HROW ) shares have been powering on, with a gain of 27% in the...

The simplest way to invest in stocks is to buy exchange traded funds. But you can do a lot better than that by buying...

Ternium S.A.'s ( NYSE:TX ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong buy right now...

To the annoyance of some shareholders, Niagen Bioscience, Inc. ( NASDAQ:NAGE ) shares are down a considerable 25% in...

Key Insights Metro's estimated fair value is CA$108 based on 2 Stage Free Cash Flow to Equity Metro's CA$93.52 share...

Reway Group (BIT:RWY) is forecasting revenue growth of 9.3% per year, well ahead of the Italian market average of 4.9%. EPS is expected to grow at 17.5% annually, outpacing the market’s 9.4% rate but not crossing the bar for “significantly” high growth. The company’s net profit margin stands at 9%, down from 9.8% in the previous year, highlighting steady growth but a slight squeeze on profitability. See our full analysis for Reway Group. The next section measures these earnings numbers...

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

With the business potentially at an important milestone, we thought we'd take a closer look at XOMA Royalty...

In late September 2025, Enanta Pharmaceuticals announced positive topline results from its Phase 2b trial of zelicapavir for treating respiratory syncytial virus (RSV) in high-risk adults, observing faster symptom resolution and a lower hospitalization rate despite not meeting the trial's primary endpoint. This proof-of-concept success provides the company with clear support to advance zelicapavir into Phase 3 development, potentially addressing significant unmet needs in the RSV market for...

Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...

Key Insights Significantly high institutional ownership implies Adverum Biotechnologies' stock price is sensitive to...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

In September 2025, JDE Peet's N.V. was added to the Amsterdam AEX Index after being removed from the AMX Index, marking a significant milestone for the coffee and tea company. This inclusion signals greater visibility for JDE Peet’s among institutional investors, as index changes often influence passive fund allocation and market presence. With JDE Peet’s joining the AEX Index, we’ll explore what this shift in index membership could mean for its investment narrative. We've found 19 US stocks...

Nature Wood Group Limited ( NASDAQ:NWGL ) shareholders have had their patience rewarded with a 36% share price jump in...

While XPEL, Inc. ( NASDAQ:XPEL ) might not have the largest market cap around , it saw significant share price movement...